PAR5 DISEASE SEVERITY AND COSTS AMONG PATIENTS STARTING A TREATMENT WITH COX-2 SPECIFIC INHIBITORS VERSUS NSAIDS PATIENTS IN ITALY- QUANTITATIVE ASSESSMENT IN 442 PATIENTS WITH ARTHRITIS
Abstract
Authors
C Lucioni A Chinellato S Mazzi D Roggeri S Chiroli